by John Leifer | Feb 8, 2016 | Healthcare, Healthcare reform, Pharmaceutical, Transparency
This article, from the Business Journal, calls on candidates to go far beyond simply bashing Obamacare and articulate a cogent path to a value-driven health care system....
by John Leifer | May 28, 2015 | Cancer, Healthcare, Healthcare reform, Pharmaceutical, Pharmaceutical
Beyond the caring rhetoric carefully crafted by providers of cancer treatment and therapeutics, there exists a motivation every bit as powerful as saving lives — reaping billions of dollars in profit. That’s what is at stake in the ongoing war on cancer...
by John Leifer | Apr 30, 2014 | Healthcare, Healthcare reform
“Health is Priceless:” A recent article in the New York Times stated that pharmaceutical companies are employing a new rationale to justify the seemingly irrationally, exorbitant prices being charged for pharmaceuticals: “Health is priceless.” While true,...
by John Leifer | Jan 21, 2014 | Healthcare, Healthcare reform
What if I told you that there was a panacea to our nation’s health care crisis? Would you burst into laughter, stop reading, or simply conclude that I could not possibly understand the complexity of issues underlying our health system’s dysfunction? After all,...
by John Leifer | Sep 13, 2013 | Healthcare, Healthcare reform
When my friends ask me to translate the 2,000+ pages of legislation constituting the Affordable Care Act (ACA), aka Obamacare, into a sound-byte, I stammer and stutter looking for where to begin. In the end, I tell them about the Good, the Bad, and the Ugly. The good...
Recent Comments